Stay updated on DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma

Sign up to get notified when there's something new on the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page.
Latest website image capture
Clouds background image

Latest updates to the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page no longer references 'Multiple myeloma' and the related MedlinePlus Genetics topics, removing core disease context from the study details.
    Difference
    0.2%
    Check dated 2025-12-09T14:18:11.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.2 in the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:36:15.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed the government funding status notice and related operating-status details from the page. The related topics sections for 'Multiple Myeloma' and 'MedlinePlus Genetics' were also removed.
    Difference
    0.5%
    Check dated 2025-11-18T06:52:22.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    No significant content changes were detected between the two screenshots; core study details, eligibility criteria, and outcomes remain unchanged. Any observed differences appear to be formatting/layout adjustments rather than substantive updates.
    Difference
    0.5%
    Check dated 2025-11-03T20:44:53.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Core content reduction: the MedlinePlus Genetics topic on multiple myeloma was removed, narrowing the page’s coverage of genetics-related information on that disease.
    Difference
    0.2%
    Check dated 2025-10-20T13:00:20.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Added MedlinePlus Genetics topic: Multiple myeloma (expands core content and resources on genetics and disease).
    Difference
    0.2%
    Check dated 2025-10-13T07:32:58.000Z thumbnail image

Stay in the know with updates to DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma

Enter your email address, and we'll notify you when there's something new on the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page.